Agreement of cardiovascular risk in ataxia-telangiectasia mutated heterozygotes and their children with Ataxia-telangiectasia

References

• Milne RL. Variants in the ATM gene and breast cancer susceptibility. Genome Med. 2009;1(1):12.
   PubMedGoogle Scholar
• Lavin MF, Lederman HM. Chromosomal breakage syndromes associated with immunodeficiency. In: Stiehm ER, Ochs HD, Winkelstein JA, editors. Immunologic disorders in infants & children. 5th ed. Philadelphia: Elsevier/Saunders; 2004. p. 580–587.
   Google Scholar
• Gatti RA, Becker-Catania S, Chun HH, et al. The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone. Clin Rev Allergy Immunol. 2001;20(1):87–108.
   PubMed Web of Science ®Google Scholar
• da Silva R, Dos Santos-Valente EC, Burim SF, et al. The relationship between nutritional status, vitamin A and zinc levels and oxidative stress in patients with ataxia-telangiectasia. Allergol Immunopathol (Madr). 2014;42(4):329–335.
   PubMed Web of Science ®Google Scholar
• Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013;121(20):4036–4045.
   PubMed Web of Science ®Google Scholar
• Swift M, Morrell D, Cromartie E, et al. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am J Hum Genet. 1986;39(5):573–583.
   PubMed Web of Science ®Google Scholar
• FitzGerald MG, Bean JM, Hegde SR, et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet. 1997;15(3):307–310.
   PubMed Web of Science ®Google Scholar
• Delia D, Mizutani S, Panigone S, et al. ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes. Br J Cancer. 2000;82(12):1938–1945.
   PubMed Web of Science ®Google Scholar
• Shigeta T, Takagi M, Delia D, et al. Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations. Cancer Res. 1999;59(11):2602–2607.
   PubMed Web of Science ®Google Scholar
• Wu D, Yang H, Xiang W, et al. Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res. 2005;46(7):1380–1387.
   PubMed Web of Science ®Google Scholar
• van Os NJ, Roeleveld N, Weemaes CM, et al. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline. Clin Genet. 2016;90(2):105–117.
   PubMed Web of Science ®Google Scholar
• Su Y, Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med. 2000;133(10):770–778.
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93(3):190–197.
   PubMed Web of Science ®Google Scholar
• Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. Ann Arbor: The University of Michigan Press; 1990. p. 189.
   Google Scholar
• de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85(9):660–667.
   PubMed Web of Science ®Google Scholar
• Lohman TG. Advances in body composition assessment: current issues in exercises science. Illinois: Human Kinetic Publisher; 1992. p. 335.
   Google Scholar
• Slaughter MH, Lohman TG, Boileau RA, et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol. 1988;60:709–723.
   PubMed Web of Science ®Google Scholar
• Deurenberg P, Pieters JJ, Hautuast JG. The assessment of the body fat percentage by skinfold thickness measurement in childhood e young adolescent. Br J Nutr. 1990;63:293–303.
   PubMed Web of Science ®Google Scholar
• Blackburn GL, Thornton PA. Nutritional assessment of the hospitalized patients. Med Clin North Am. 1979;63:11103–11115.
   PubMed Web of Science ®Google Scholar
• Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–286.
   PubMed Web of Science ®Google Scholar
• Kuba VM, Leone C, Damiani D. Is waist-to-height ratio a useful indicator of cardio-metabolic risk in 6-10-yearold children? BMC Pediatr. 2013;13:91.
   PubMed Web of Science ®Google Scholar
• Daniels SR, Greer FR; Committee on nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198–208.
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–3421.
   PubMed Web of Science ®Google Scholar
• Srinivasan SR, Frontini MG, Xu J, et al. Utility of childhood non-high densitylipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa heart study. Pediatrics. 2006;118:201–206.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidence. J Intern Med. 2006;259(5):493–519.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, von Kegler S, Steinmetz H, et al. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37(1):87–92.
   PubMed Web of Science ®Google Scholar
• Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991. p. 611p.
   Google Scholar
• Verbeek R, Hovingh GK, Boekholdt SM. Non-high-density lipoprotein cholesterol: current status as cardiovascular marker. Curr Opin Lipidol. 2015;26:502–510.
   PubMed Web of Science ®Google Scholar
• Cao Y, Yan L, Guo N, et al. Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;147:1–8.
   PubMed Web of Science ®Google Scholar
• Brunner FJ, Waldeyer C, Ojeda F, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the multinational cardiovascular risk consortium. Lancet. 2019;394(10215):2173–2183.
   PubMed Web of Science ®Google Scholar
• Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–765.
   PubMedGoogle Scholar
• Paulino TL, Rafael MN, Hix S, et al. Is age a risk factor for liver disease and metabolic alterations in ataxia telangiectasia patients? Orphanet J Rare Dis. 2017;12(1):136.
   PubMedGoogle Scholar
• Andrade IG, Costa-Carvalho BT, da Silva R, et al. Risk of atherosclerosis in patients with ataxia telangiectasia. Ann Nutr Metab. 2015;66(4):196–201.
   PubMed Web of Science ®Google Scholar
• Schneider JG, Finck BN, Ren J, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab. 2006;4(5):377–389.
   PubMed Web of Science ®Google Scholar
• Foster CR, Singh M, Subramanian V, et al. Ataxia telangiectasia mutated kinase plays a protective role in β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Mol Cell Biochem. 2011;353(1–2):13–22.
   PubMed Web of Science ®Google Scholar
• Foster CR, Zha Q, Daniel LL, et al. Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: role in β-adrenergic receptor-stimulated apoptosis. Exp Physiol. 2012;97(4):506–515.
   PubMed Web of Science ®Google Scholar
• Viniegra JG, Martínez N, Modirassari P, et al. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem. 2005;280(6):4029–4036.
   PubMed Web of Science ®Google Scholar
• Mercer JR, Cheng KK, Figg N, et al. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res. 2010;107(8):1021–1031.
   PubMed Web of Science ®Google Scholar
• Kotchetkoff ECA, Souza FIS, Fonseca FLA, et al. Assessing cardiovascular risk in ATM heterozygotes. Rev Assoc Med Bras (1992). 2018;64(2):148–153.
   PubMed Web of Science ®Google Scholar
• Eikendal AL, Groenewegen KA, Anderson TJ, et al.; USE-IMT Project Group. Common carotid intima-media thickness relates to cardiovascular events in adults aged < 45 years. Hypertension. 2015;65(4):707–713.
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–467.
   PubMed Web of Science ®Google Scholar
• Smirnov DA, Cheung VG. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs. Am J Hum Genet. 2008;83(2):243–253.
   PubMed Web of Science ®Google Scholar
• Foster CR, Daniel LL, Daniels CR, et al. Deficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis. PLoS One. 2013;8(12):e83513.
   PubMed Web of Science ®Google Scholar